Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Dyne Therapeutics Inc (NQ: DYN ) 33.07 -0.62 (-1.84%) Streaming Delayed Price Updated: 4:00 PM EDT, Jun 14, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 579,554 Open 33.00 Bid (Size) 31.40 (1) Ask (Size) 40.00 (1) Prev. Close 33.69 Today's Range 32.64 - 33.40 52wk Range 6.400 - 35.98 Shares Outstanding 58,310,703 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Dyne Therapeutics Presents New Preclinical Data for its Facioscapulohumeral Muscular Dystrophy Program During the FSHD Society International Research Congress June 13, 2024 From Dyne Therapeutics, Inc. Via GlobeNewswire Casey's Reports Upbeat Earnings, Joins Avidity Biosciences, Rentokil Initial And Other Big Stocks Moving Higher On Wednesday June 12, 2024 Via Benzinga Performance YTD +153.22% +153.22% 1 Month +15.03% +15.03% 3 Month +25.84% +25.84% 6 Month +177.20% +177.20% 1 Year +202.01% +202.01% More News Read More Soft Inflation Data Boosts Small Caps, Real Estate, Regional Banks; Traders Anticipate Fed Rate Cuts As Stocks React June 12, 2024 Via Benzinga Topics Economy Exposures Interest Rates The 3 Most Undervalued Biotech Stocks to Buy in June 2024 June 04, 2024 Via InvestorPlace Dyne Therapeutics to Present at Jefferies Global Healthcare Conference May 30, 2024 From Dyne Therapeutics, Inc. Via GlobeNewswire Dyne Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares May 28, 2024 From Dyne Therapeutics, Inc. Via GlobeNewswire Modine Manufacturing Posts Mixed Q4 Results, Joins Viasat, Lululemon And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session May 22, 2024 Via Benzinga Dyne Therapeutics Announces Pricing of $325.5 Million Public Offering of Common Stock May 21, 2024 From Dyne Therapeutics, Inc. Via GlobeNewswire Dyne Therapeutics Announces Proposed Public Offering of Common Stock May 20, 2024 From Dyne Therapeutics, Inc. Via GlobeNewswire Why Is Dyne Therapeutics Stock Soaring On Monday? May 20, 2024 Via Benzinga Tech Surge Boosts Nasdaq To Record Highs May 20, 2024 Via Talk Markets Topics Stocks Exposures US Equities Why Dyne Therapeutics, With A 108% Run This Year, Just Catapulted Again May 20, 2024 Via Investor's Business Daily Overseas Shipholding, Micron, Squarespace, Incyte And Other Big Stocks Moving Higher On Monday May 20, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday May 20, 2024 Via InvestorPlace Dyne Therapeutics Announces New Clinical Data from ACHIEVE Trial of DYNE-101 in DM1 and DELIVER Trial of DYNE-251 in DMD Demonstrating Compelling Impact on Key Disease Biomarkers and Improvement in Multiple Functional Endpoints May 20, 2024 From Dyne Therapeutics, Inc. Via GlobeNewswire Dyne Therapeutics to Host Virtual Investor Event to Review New Clinical Data from the ACHIEVE and DELIVER Trials Tomorrow, May 20 at 8:00 a.m. ET May 19, 2024 From Dyne Therapeutics, Inc. Via GlobeNewswire DYN Stock Earnings: Dyne Therapeutics Misses EPS for Q1 2024 May 02, 2024 Via InvestorPlace Dyne Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights May 02, 2024 From Dyne Therapeutics, Inc. Via GlobeNewswire Dyne Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed President and Chief Executive Officer March 27, 2024 From Dyne Therapeutics, Inc. Via GlobeNewswire Dyne Therapeutics to Present at the Cantor Virtual Muscular Dystrophy Symposium March 27, 2024 From Dyne Therapeutics, Inc. Via GlobeNewswire Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session March 25, 2024 Via Benzinga Aehr Test Systems Reports Preliminary Results, Joins Dyne Therapeutics, United Airlines And Other Big Stocks Moving Lower On Monday March 25, 2024 Via Benzinga Topics Stocks Exposures US Equities Dyne Therapeutics Announces CEO Transition March 25, 2024 From Dyne Therapeutics, Inc. Via GlobeNewswire Neuromuscular Focused-Avidity Biosciences Has 'Complete Package' - Analyst Predicts Stellar 142% Stock Surge March 14, 2024 Via Benzinga Dyne Therapeutics to Present at Stifel 2024 Virtual CNS Days March 13, 2024 From Dyne Therapeutics, Inc. Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
